Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Is vasectomy a cause of prostate cancer?

Mucci LA, Wilson KM, Preston MA, Giovannucci EL.

J Natl Cancer Inst. 2019 May 23. pii: djz102. doi: 10.1093/jnci/djz102. [Epub ahead of print] No abstract available.

PMID:
31119274
2.

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA.

Hanna N, Trinh QD, Seisen T, Vetterlein MW, Sammon J, Preston MA, Lipsitz SR, Bellmunt J, Menon M, Choueiri TK, Abdollah F.

Eur Urol Oncol. 2018 May;1(1):83-90. doi: 10.1016/j.euo.2018.03.001. Epub 2018 May 15.

PMID:
31100232
3.

Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.

Downer MK, Allard CB, Preston MA, Wilson KM, Kenfield SA, Chan JM, Mucci LA, Giovannucci E, Stampfer MJ.

Eur Urol Oncol. 2019 Mar;2(2):126-134. doi: 10.1016/j.euo.2018.07.002. Epub 2018 Jul 31.

PMID:
31017087
4.

Unbiased screen of RNA tailing activities reveals a poly(UG) polymerase.

Preston MA, Porter DF, Chen F, Buter N, Lapointe CP, Keles S, Kimble J, Wickens M.

Nat Methods. 2019 May;16(5):437-445. doi: 10.1038/s41592-019-0370-6. Epub 2019 Apr 15.

PMID:
30988468
5.

Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy.

Gild P, Nguyen DD, Fletcher SA, Cole AP, Lipsitz SR, Kibel AS, Fisch M, Preston MA, Trinh QD.

Clin Genitourin Cancer. 2019 Jun;17(3):e488-e493. doi: 10.1016/j.clgc.2019.01.009. Epub 2019 Jan 29.

PMID:
30837209
6.

Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years.

Salari K, Kuppermann D, Preston MA, Dahl DM, Barrisford GW, Efstathiou JA, Blute ML, Vesprini D, Loblaw A, Zietman AL, Klotz L, Feldman AS.

J Urol. 2019 Apr;201(4):721-727. doi: 10.1097/JU.0000000000000031.

PMID:
30664083
7.

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Intravenous Acetaminophen Versus Placebo in Patients Undergoing Robotic-Assisted Laparoscopic Prostatectomy.

Wang VC, Preston MA, Kibel AS, Xu X, Gosnell J, Yong RJ, Urman RD.

J Pain Palliat Care Pharmacother. 2018 Jun - Sep;32(2-3):82-89. doi: 10.1080/15360288.2018.1513436. Epub 2019 Jan 15.

PMID:
30645153
8.

Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?

Cole AP, Fletcher SA, Berg S, Nabi J, Mahal BA, Sonpavde GP, Nguyen PL, Lipsitz SR, Sun M, Choueiri TK, Preston MA, Kibel AS, Trinh QD.

Cancer. 2019 Apr 15;125(8):1319-1329. doi: 10.1002/cncr.31926. Epub 2019 Jan 11.

PMID:
30633323
9.

A novel myelin protein zero transgenic zebrafish designed for rapid readout of in vivo myelination.

Preston MA, Finseth LT, Bourne JN, Macklin WB.

Glia. 2019 Apr;67(4):650-667. doi: 10.1002/glia.23559. Epub 2019 Jan 9.

PMID:
30623975
10.

Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes.

Abufaraj M, Foerster B, Schernhammer E, Moschini M, Kimura S, Hassler MR, Preston MA, Karakiewicz PI, Remzi M, Shariat SF.

Eur Urol. 2019 Apr;75(4):649-658. doi: 10.1016/j.eururo.2018.11.052. Epub 2018 Dec 13. Review.

PMID:
30553613
11.

Examining the relationship between complications and perioperative mortality following radical cystectomy: a population-based analysis.

Mossanen M, Krasnow RE, Zlatev DV, Tan WS, Preston MA, Trinh QD, Kibel AS, Sonpavde G, Schrag D, Chung BI, Chang SL.

BJU Int. 2019 Jul;124(1):40-46. doi: 10.1111/bju.14636. Epub 2019 Apr 14.

PMID:
30499636
12.

Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories.

Mossanen M, Wang Y, Szymaniak J, Tan WS, Huynh MJ, Preston MA, Trinh QD, Sonpavde G, Kibel AS, Chang SL.

World J Urol. 2018 Nov 16. doi: 10.1007/s00345-018-2550-x. [Epub ahead of print]

PMID:
30446799
13.

Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.

Preston MA, Gerke T, Carlsson SV, Signorello L, Sjoberg DD, Markt SC, Kibel AS, Trinh QD, Steinwandel M, Blot W, Vickers AJ, Lilja H, Mucci LA, Wilson KM.

Eur Urol. 2019 Mar;75(3):399-407. doi: 10.1016/j.eururo.2018.08.032. Epub 2018 Sep 17.

PMID:
30237027
14.

Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery After Surgery Protocol.

Chiang HA, Cheng PJ, Speed JM, Steinberg J, Najjar PA, Steele GS, Trinh QD, Eswara JR, Chang SL, Kibel AS, Stopfkuchen-Evans MF, Preston MA.

Eur Urol Focus. 2018 Sep 15. pii: S2405-4569(18)30244-X. doi: 10.1016/j.euf.2018.08.025. [Epub ahead of print]

PMID:
30228076
15.

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Downs TM, Efstathiou JA, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Petrylak DP, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Tward J, Wile G, Johnson-Chilla A, Dwyer MA, Gurski LA.

J Natl Compr Canc Netw. 2018 Sep;16(9):1041-1053. doi: 10.6004/jnccn.2018.0072.

PMID:
30181416
16.

Contemporary perceptions of human papillomavirus and penile cancer: Perspectives from a national survey.

Zavaski ME, Hanske J, Löppenberg B, Cole AP, Hanna N, Gupta S, Eswara JR, Preston MA, Kibel AS, Lipsitz SR, Sun M, Trinh QD, Meyer CP.

Can Urol Assoc J. 2019 Feb;13(2):32-37. doi: 10.5489/cuaj.5366. Epub 2018 Jul 31.

17.

Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era.

Fletcher SA, Harmouch SS, Krimphove MJ, Cole AP, Berg S, Gild P, Preston MA, Sonpavde GP, Kibel AS, Sun M, Choueiri TK, Trinh QD.

World J Urol. 2018 Nov;36(11):1767-1774. doi: 10.1007/s00345-018-2371-y. Epub 2018 Jun 14.

PMID:
29948050
18.

Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54].

Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, Jordan S, Severi G, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TE, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Gaziano JM, Sesso HS, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Colli LM, Sampson JN, Besse C, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Mijuskovic M, Ognjanovic M, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Bueno-de-Mesquita HBA, Canzian F, Duell EJ, Ljungberg B, Sitaram RT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Larkin J, Choueiri TK, Lathrop GM, Teh BT, Deleuze JF, Wu X, Houlston RS, Brennan P, Chanock SJ, Scelo G, Purdue MP.

Eur Urol. 2018 Sep;74(3):e85-e86. doi: 10.1016/j.eururo.2018.05.017. Epub 2018 May 28. No abstract available.

PMID:
29853305
19.

Dietary Acrylamide Intake and Risk of Renal Cell Carcinoma in Two Large Prospective Cohorts.

Graff RE, Cho E, Preston MA, Sanchez A, Mucci LA, Wilson KM.

Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):979-982. doi: 10.1158/1055-9965.EPI-18-0320. Epub 2018 May 14.

PMID:
29760239
20.

Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies.

Graff RE, Sanchez A, Tobias DK, Rodríguez D, Barrisford GW, Blute ML, Li Y, Sun Q, Preston MA, Wilson KM, Cho E.

Diabetes Care. 2018 Jul;41(7):1432-1437. doi: 10.2337/dc17-2518. Epub 2018 Apr 20.

PMID:
29678810
21.

Insurance coverage mandates: Impact of physician utilization in moderating colorectal cancer screening rates.

Preston MA, Mays GP, Bursac Z, Thomas BR, Laryea J, Tilford JM, Odlum M, Smith SA, Henry-Tillman RS.

Am J Surg. 2018 Jun;215(6):1004-1010. doi: 10.1016/j.amjsurg.2018.02.026. Epub 2018 Mar 2.

PMID:
29555083
22.

The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.

Fletcher SA, Gild P, Cole AP, Vetterlein MW, Kibel AS, Choueiri TK, Sonpavde GP, Preston MA, Pucheril D, Menon M, Sun M, Lipsitz SR, Trinh QD.

Urol Oncol. 2018 May;36(5):238.e7-238.e17. doi: 10.1016/j.urolonc.2018.01.010. Epub 2018 Feb 15.

PMID:
29454591
23.

Reply to Christian D. Fankhauser, Nico C. Grossmann, Joerg Beyer, and Thomas Hermanns' Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70.

Kamran SC, Seisen T, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Apr;73(4):e96-e97. doi: 10.1016/j.eururo.2017.12.026. Epub 2018 Jan 19. No abstract available.

PMID:
29358058
24.

Bladder cancer local staging: multiparametric MRI performance following transurethral resection.

van der Pol CB, Shinagare AB, Tirumani SH, Preston MA, Vangel MG, Silverman SG.

Abdom Radiol (NY). 2018 Sep;43(9):2412-2423. doi: 10.1007/s00261-017-1449-0.

PMID:
29313114
25.

Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade.

McKay RR, Montgomery B, Xie W, Zhang Z, Bubley GJ, Lin DW, Preston MA, Trinh QD, Chang P, Wagner AA, Mostaghel EA, Kantoff PW, Nelson PS, Kibel AS, Taplin ME.

Prostate Cancer Prostatic Dis. 2018 Sep;21(3):364-372. doi: 10.1038/s41391-017-0009-6. Epub 2017 Dec 20.

PMID:
29263420
26.

Reply to Aditya Bagrodia, Solomon Woldu, David F. Penson, Alexander Kutikov, and Samuel D. Kaffenberger's Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70.

Seisen T, Kamran SC, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Apr;73(4):e100-e101. doi: 10.1016/j.eururo.2017.10.013. Epub 2017 Nov 3. No abstract available.

PMID:
29108659
27.

Associations of specific postoperative complications with costs after radical cystectomy.

Mossanen M, Krasnow RE, Lipsitz SR, Preston MA, Kibel AS, Ha A, Gore JL, Smith AB, Leow JJ, Trinh QD, Chang SL.

BJU Int. 2018 Mar;121(3):428-436. doi: 10.1111/bju.14064. Epub 2017 Nov 16.

28.

Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, Downs TM, Efstathiou JA, Flaig TW, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Sonpavde G, Tward J, Wile G, Dwyer MA, Gurski LA.

J Natl Compr Canc Netw. 2017 Oct;15(10):1240-1267. doi: 10.6004/jnccn.2017.0156.

PMID:
28982750
29.

Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer.

Vetterlein MW, Seisen T, Leow JJ, Preston MA, Sun M, Friedlander DF, Meyer CP, Chun FK, Lipsitz SR, Menon M, Kibel AS, Bellmunt J, Choueiri TK, Trinh QD.

Clin Genitourin Cancer. 2017 Aug 24. pii: S1558-7673(17)30248-3. doi: 10.1016/j.clgc.2017.08.007. [Epub ahead of print]

PMID:
28899722
30.

Quality Improvement Efforts in Radical Cystectomy: From Prehab to Rehab.

Mossanen M, Preston MA.

Eur Urol. 2017 Aug 31. pii: S0302-2838(17)30710-8. doi: 10.1016/j.eururo.2017.08.017. [Epub ahead of print] No abstract available.

PMID:
28867447
31.

Colorectal cancer screening in rural and poor-resourced communities.

Preston MA, Glover-Collins K, Ross L, Porter A, Bursac Z, Woods D, Burton J, Crowell K, Laryea J, Henry-Tillman RS.

Am J Surg. 2018 Aug;216(2):245-250. doi: 10.1016/j.amjsurg.2017.08.004. Epub 2017 Aug 12.

PMID:
28842164
32.

Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA.

Leow JJ, Cole AP, Seisen T, Bellmunt J, Mossanen M, Menon M, Preston MA, Choueiri TK, Kibel AS, Chung BI, Sun M, Chang SL, Trinh QD.

Eur Urol. 2017 Aug 9. pii: S0302-2838(17)30640-1. doi: 10.1016/j.eururo.2017.07.016. [Epub ahead of print]

PMID:
28803034
33.

Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.

Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, Jordan S, Severi G, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TE, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Gaziano JM, Sesso HS, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Colli LM, Sampson JN, Besse C, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Mijuskovic M, Ognjanovic M, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Bueno-de-Mesquita HB, Canzian F, Duell EJ, Ljungberg B, Sitaram RT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Larkin J, Choueiri TK, Lathrop GM, Teh BT, Deleuze JF, Wu X, Houlston RS, Brennan P, Chanock SJ, Scelo G, Purdue MP.

Eur Urol. 2017 Nov;72(5):747-754. doi: 10.1016/j.eururo.2017.07.015. Epub 2017 Aug 7. Erratum in: Eur Urol. 2018 May 28;:.

34.

Architecture and dynamics of overlapped RNA regulatory networks.

Lapointe CP, Preston MA, Wilinski D, Saunders HAJ, Campbell ZT, Wickens M.

RNA. 2017 Nov;23(11):1636-1647. doi: 10.1261/rna.062687.117. Epub 2017 Aug 2.

35.

Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.

Vetterlein MW, Wankowicz SAM, Seisen T, Lander R, Löppenberg B, Chun FK, Menon M, Sun M, Barletta JA, Choueiri TK, Bellmunt J, Trinh QD, Preston MA.

Cancer. 2017 Nov 15;123(22):4346-4355. doi: 10.1002/cncr.30907. Epub 2017 Jul 25.

36.

Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer.

Kamran SC, Seisen T, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Feb;73(2):262-270. doi: 10.1016/j.eururo.2017.06.013. Epub 2017 Jul 4.

PMID:
28687143
37.

Editorial comment.

Sonpavde G, Preston MA.

Urology. 2017 Aug;106:124. doi: 10.1016/j.urology.2017.04.050. Epub 2017 Jun 22. No abstract available.

PMID:
28648973
38.

Genome-wide association study identifies multiple risk loci for renal cell carcinoma.

Scelo G, Purdue MP, Brown KM, Johansson M, Wang Z, Eckel-Passow JE, Ye Y, Hofmann JN, Choi J, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Sampson JN, Abedi-Ardekani B, Besse C, Blanche H, Boland A, Burdette L, Chabrier A, Durand G, Le Calvez-Kelm F, Prokhortchouk E, Robinot N, Skryabin KG, Wozniak MB, Yeager M, Basta-Jovanovic G, Dzamic Z, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Baglietto L, Boeing H, Khaw KT, Weiderpass E, Ljungberg B, Sitaram RT, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Michael Gaziano J, Sesso HD, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Henrion M, Larkin J, Barman P, Leibovich BC, Choueiri TK, Mark Lathrop G, Rothman N, Deleuze JF, McKay JD, Parker AS, Wu X, Houlston RS, Brennan P, Chanock SJ.

Nat Commun. 2017 Jun 9;8:15724. doi: 10.1038/ncomms15724.

39.

Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.

Seisen T, Sun M, Lipsitz SR, Abdollah F, Leow JJ, Menon M, Preston MA, Harshman LC, Kibel AS, Nguyen PL, Bellmunt J, Choueiri TK, Trinh QD.

Eur Urol. 2017 Oct;72(4):483-487. doi: 10.1016/j.eururo.2017.03.038. Epub 2017 Apr 12.

PMID:
28412065
40.

Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United States.

Krasnow RE, Mossanen M, Koo S, Kubiak DW, Preston MA, Chung BI, Kibel AS, Chang SL.

J Urol. 2017 Aug;198(2):297-304. doi: 10.1016/j.juro.2017.02.3340. Epub 2017 Mar 4.

PMID:
28267603
41.

Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.

Downer MK, Allard CB, Preston MA, Gaziano JM, Stampfer MJ, Mucci LA, Batista JL.

Eur Urol. 2017 Nov;72(5):821-827. doi: 10.1016/j.eururo.2017.01.044. Epub 2017 Feb 8.

PMID:
28189429
42.

Editorial Comment.

Preston MA.

J Urol. 2017 Apr;197(4):1075. doi: 10.1016/j.juro.2016.10.131. Epub 2017 Jan 13. No abstract available.

PMID:
28093246
43.

Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.

Seisen T, Krasnow RE, Bellmunt J, Rouprêt M, Leow JJ, Lipsitz SR, Vetterlein MW, Preston MA, Hanna N, Kibel AS, Sun M, Choueiri TK, Trinh QD, Chang SL.

J Clin Oncol. 2017 Mar 10;35(8):852-860. doi: 10.1200/JCO.2016.69.4141. Epub 2017 Jan 3.

PMID:
28045620
44.

The Quality and Utility of Surgical and Anesthetic Data at a Ugandan Regional Referral Hospital.

Tumusiime G, Was A, Preston MA, Riesel JN, Ttendo SS, Firth PG.

World J Surg. 2017 Feb;41(2):370-379. doi: 10.1007/s00268-016-3714-8.

PMID:
27658805
45.

Meat, Fish, Poultry, and Egg Intake at Diagnosis and Risk of Prostate Cancer Progression.

Wilson KM, Mucci LA, Drake BF, Preston MA, Stampfer MJ, Giovannucci E, Kibel AS.

Cancer Prev Res (Phila). 2016 Dec;9(12):933-941. Epub 2016 Sep 20.

46.

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

Albiges L, Hakimi AA, Xie W, McKay RR, Simantov R, Lin X, Lee JL, Rini BI, Srinivas S, Bjarnason GA, Ernst S, Wood LA, Vaishamayan UN, Rha SY, Agarwal N, Yuasa T, Pal SK, Bamias A, Zabor EC, Skanderup AJ, Furberg H, Fay AP, de Velasco G, Preston MA, Wilson KM, Cho E, McDermott DF, Signoretti S, Heng DYC, Choueiri TK.

J Clin Oncol. 2016 Oct 20;34(30):3655-3663. doi: 10.1200/JCO.2016.66.7311.

47.

Resident Involvement in Radical Inguinal Orchiectomy for Testicular Cancer Does Not Adversely Impact Perioperative Outcomes - A Retrospective Study.

Vetterlein MW, Seisen T, Löppenberg B, Hanna N, Cheng PJ, Fisch M, Chun FK, Kibel AS, Preston MA, Meyer CP.

Urol Int. 2017;98(4):472-477. doi: 10.1159/000448596. Epub 2016 Aug 31.

PMID:
27577733
48.

Retrospective Descriptive Study of an Intensive Care Unit at a Ugandan Regional Referral Hospital.

Ttendo SS, Was A, Preston MA, Munyarugero E, Kerry VB, Firth PG.

World J Surg. 2016 Dec;40(12):2847-2856. doi: 10.1007/s00268-016-3644-5.

PMID:
27506722
49.

Patterns of Recurrence in Upper Tract Transitional Cell Carcinoma: Imaging Surveillance.

Mao Y, Kilcoyne A, Hedgire S, Preston MA, McGovern FJ, Dahl DM, Harisinghani M.

AJR Am J Roentgenol. 2016 Oct;207(4):789-796. doi: 10.2214/AJR.16.16064. Epub 2016 Jul 6.

PMID:
27382922
50.

Moving Towards Widespread Implementation of Enhanced Recovery Protocols for Radical Cystectomy.

Cheng PJ, Preston MA.

Eur Urol. 2016 Dec;70(6):1004-1005. doi: 10.1016/j.eururo.2016.06.017. Epub 2016 Jun 24. No abstract available.

PMID:
27349613

Supplemental Content

Loading ...
Support Center